Last reviewed · How we verify
NCT04866277: STOP-LBW
Experimental Study to Reduce Low Birthweight
NA trial testing Fast-track referral for reference services in Infant, Low Birth Weight in 2,832 participants. Status unknown.
30 December 2021
Quick facts
| Lead sponsor | Instituto de Saude Publica da Universidade do Porto |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 2,832 |
| Start date | 2 May 2021 |
| Primary completion | 30 December 2021 |
| Estimated completion | 31 January 2022 |
Drugs / interventions tested
- Fast-track referral for reference services
Conditions studied
- Infant, Low Birth Weight — all drugs for Infant, Low Birth Weight →
Sponsor
Instituto de Saude Publica da Universidade do Porto
Who can join
Adults 14 to 49, female only, with Infant, Low Birth Weight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Low birthweight (LBW) is associated with a wide range of short- and long-term consequences and is related to a complex set of maternal psychosocial and behavioural determinants. The objective of this study is to assess the effect of implementing fast-track referral for early intervention on psychosocial and behavioural risk factors - smoking, alcohol consumption, depression and interpersonal violence - on reducing the incidence of LBW. Methods and analysis: Parallel superiority pragmatic clinical trial randomized by clusters. Primary health care units (PHCU) located in Portugal will be randomized (1:1) to intervention or control groups. Pregnant women over 14 years of age attending these PHCU will be eligible to the study. Risk factors will be assessed through face-to-face interviews. In the intervention group, women who report at least one risk factor will have immediate access to referral services. The comparison group will be the local standard of care for these risk factors. The investigators will use intention-to-treat analyses to compare intervention and control groups. A sample size of 2,832 pregnant women was estimated to detect a 30% reduction in the incidence rate of LBW (primary outcome) between the control and intervention groups. Secondary outcomes are the reduction of preterm births and reduction of risk factors targeted by the intervention.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy.
Minozzi S, Ambrosi L, Saulle R, Uhm SS, et al · · 2024 · cited 6× · PMID 38682758 · DOI 10.1002/14651858.cd015042.pub2 -
Fast-track referral for health interventions during pregnancy: study protocol of a randomised pragmatic experimental study to reduce low birth weight in Portugal (STOP LBW).
Barros H, Baia I, Monjardino T, Pimenta P, et al · · 2022 · cited 3× · PMID 35292492 · DOI 10.1136/bmjopen-2021-052964
Verify or expand the search:
- PubMed search for NCT04866277
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infant, Low Birth Weight
Currently open trials in the same condition.
- NCT00009633 — Follow-up Visit of High Risk Infants · recruiting
- NCT00063063 — Generic Database of Very Low Birth Weight Infants · recruiting
Other Instituto de Saude Publica da Universidade do Porto trials
Trials by the same sponsor.
- NCT06915610 — Reengineering Cervical Cancer Screening for the 21st Century: Joint Action for a Novel Up-to-date and Sustainable Screen · NA · enrolling by invitation
- NCT05046769 — COVID-19: A Scope Research on Epidemiology and Clinical Course · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04866277 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Instituto de Saude Publica da Universidade do Porto
- Last refreshed: 4 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04866277.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing